Reported about 19 hours ago
In a recent update on trending tickers, Wall Street is closely monitoring Constellation Brands, which has lowered its fiscal 2026 earnings outlook due to a tough economic climate affecting consumer demand. Novo Nordisk reported promising trial data for its weight loss drug Wegovy, showcasing its potential to reduce heart-related risks. Additionally, Klarna is preparing for its initial public offering (IPO) on the New York Stock Exchange, aiming to raise $1.27 billion, although its launch has faced delays.
Source: YAHOO